Baidu
map

2021 APSC共识建议:亚太地区P2Y12受体拮抗剂的应用—特殊人群

2021-11-08 亚太心脏病学会 Eur Cardiol

2021年11月,亚太心脏病学会(APSC)发布了亚太地区特殊人群P2Y12受体拮抗剂的应用共识建议。

中文标题:

2021 APSC共识建议:亚太地区P2Y12受体拮抗剂的应用—特殊人群

英文标题:

2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1 2 Receptor Antagonists in the Asia-Pacific Region: Special Populations

发布机构:

亚太心脏病学会

发布日期:

2021-11-08

简要介绍:

2021年11月,亚太心脏病学会(APSC)发布了亚太地区特殊人群P2Y12受体拮抗剂的应用共识建议。高龄、糖尿病和慢性肾脏病不仅会增加慢性冠脉综合征(CCS)患者缺血事件的风险,也会增加抗血小板治疗期间出血风险。本文主要针对特殊人群中P2Y12受体拮抗剂的应用提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 APSC共识建议:亚太地区P2Y12受体拮抗剂的应用—特殊人群.pdf)] GetToolGuiderByIdResponse(projectId=1, id=de97c1c0022e238a, title=2021 APSC共识建议:亚太地区P2Y12受体拮抗剂的应用—特殊人群, enTitle=2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1 2 Receptor Antagonists in the Asia-Pacific Region: Special Populations, guiderFrom=Eur Cardiol, authorId=0, author=, summary=2021年11月,亚太心脏病学会(APSC)发布了亚太地区特殊人群P2Y12受体拮抗剂的应用共识建议。, cover=https://img.medsci.cn/20211126/1637935575484_1608702.jpg, journalId=0, articlesId=null, associationId=2024, associationName=亚太心脏病学会, associationIntro=亚太心脏病学会(APSC,Asia-Pacific Society of Cardiology), copyright=0, guiderPublishedTime=Mon Nov 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月,亚太心脏病学会(APSC)发布了亚太地区特殊人群P2Y12受体拮抗剂的应用共识建议。高龄、糖尿病和慢性肾脏病不仅会增加慢性冠脉综合征(CCS)患者缺血事件的风险,也会增加抗血小板治疗期间出血风险。本文主要针对特殊人群中P2Y12受体拮抗剂的应用提供指导建议。</span></p>, tagList=[TagDto(tagId=96931, tagName=P2Y12受体拮抗剂)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=96931, guiderKeyword=P2Y12受体拮抗剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1772, appHits=43, showAppHits=0, pcHits=564, showPcHits=1729, likes=1, shares=2, comments=1, approvalStatus=1, publishedTime=Sun Nov 28 13:46:49 CST 2021, publishedTimeString=2021-11-08, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Fri Nov 26 22:10:32 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 04:03:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 APSC共识建议:亚太地区P2Y12受体拮抗剂的应用—特殊人群.pdf)])
2021 APSC共识建议:亚太地区P2Y12受体拮抗剂的应用—特殊人群.pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1074946, encodeId=125b10e4946f4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:59:23 CST 2021, time=2021-11-29, status=1, ipAttribution=)]
    2021-11-29 微探

    学习学习

    0

Baidu
map
Baidu
map
Baidu
map